Concepedia

Publication | Open Access

Pathological findings in central nervous system demyelination associated with infliximab

DOIFull Paper Access

20

Citations

7

References

2019

Year

Alicja Kalinowska, Mahboobeh Fereidan-Esfahani, Yong Guo, Claudia F. Lucchinetti, W. Oliver Tobin
Multiple Sclerosis Journal

Abstract

Infliximab treatment is associated with CNS inflammatory demyelinating activity, which is histopathologically indistinguishable from MS.

References

YearCitations

Page 1